# Avihai Sodri

> Avihai Sodri is the co-founder and CEO of Antidote Health. Before co-founding the company in 2020, he worked in insurance and business development at Leumit Health Services and was CEO of Vectis Claims Services from 2016 to 2019. His public interviews emphasise teamwork and his experience managing established operations before building a company of his own.

- **Role:** Co-founder and CEO at Antidote Health
- **Organizations:** Antidote Health, Vectis Claims Services, Leumit Health Services
- **Education:** The College of Management Academic Studies
- **Known for:** Co-founded and leads Antidote Health., Previously established and led Vectis Claims Services as a Munich Re subsidiary, according to his 2024 interview., Led Antidote through announced seed and Series A financing rounds and a further initial fundraising close in December 2024.

## Career timeline

- **2010-2015** — Head of Insurance and Business Development at Leumit Health Services, according to his company leadership biography on Welcome to the Jungle.
- **2016-2019** — CEO of Vectis Claims Services.
- **2017** — Completed a Munich Re workshop on reinsurance programmes, pricing and solvency in March.
- **2019** — Vectis Claims Services was acquired by Swiss Re, according to CTech.
- **2020** — Co-founded Antidote Health with Carine Belle-Feder, David Zlotnick and Ben Enosh.
- **2021** — Antidote launched its consumer service in January and announced a $12 million seed round in August.
- **2022** — Antidote announced a $22 million Series A in March, added Giannis Antetokounmpo as investor and ambassador in August, and confirmed layoffs in October.
- **2024** — Antidote announced an initial $22 million fundraising close in December.
- **2026** — Antidote announced planned expansion into Texas and Georgia for 2027.

## Achievements

- Co-founded and leads Antidote Health.
- Previously established and led Vectis Claims Services as a Munich Re subsidiary, according to his 2024 interview.
- Led Antidote through announced seed and Series A financing rounds and a further initial fundraising close in December 2024.

## Latest updates

- **2026-10** — On October 21, Antidote announced planned entry into Texas and Georgia for Plan Year 2027; the announcement identified Sodri as co-founder and CEO.

## Links

- Website: https://www.antidotehealth.com/
- LinkedIn: https://www.linkedin.com/in/avihaisoudri

---

Profile page: https://yespress.io/avihai-sodri
Published by YesPress — https://yespress.io
Last updated: 2026-10-26